Although direct measurement of methemoglobin was not performed in the present study, it is unlikely that the dogs experienced any clinically relevant methemoglobinemia since the total dose of GTN received by each individual dog was relatively low. This evidence concerns the gene HBG2 and methemoglobinemia.